Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RNTXRein Therapeutics, Inc.

Nasdaq · CIK 0001420565
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts292

Identity from submissions API

NameRein Therapeutics, Inc.
CIK0001420565
TickersRNTX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN134196017
LEI—
Fiscal year end1231
State of incorporation—
Phone7378021989
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Aileron Therapeutics, Inc. (2024-04-01T04:00:00.000Z → 2024-12-09T05:00:00.000Z)
  • AILERON THERAPEUTICS INC (2007-12-03T05:00:00.000Z → 2024-03-29T04:00:00.000Z)
Business address
12407 N. MOPAC EXPY.
SUITE 250 #390
AUSTIN
TX
78758
TX
Mailing address
12407 N. MOPAC EXPY.
SUITE 250 #390
AUSTIN
TX
78758
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

527 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 8-K 8-K 8.01,9.01 0001193125-26-462261 001-38130 261555754 34 290912 1 1
2026-11-16 10-Q 10-Q 0001193125-26-461944 001-38130 261555246 34 10635320 1 1
2026-09-04 8-K 8-K 7.01,9.01 0001193125-26-383726 001-38130 261362470 34 21926319 1 1
2026-08-27 8-K 8-K 3.01 0001193125-26-371260 001-38130 261330153 34 141717 1 1
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097425 005-90032 261284499 34 15137
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097114 005-90032 261281404 34 11283
2026-08-14 10-Q 10-Q 0001193125-26-350270 001-38130 261275929 34 10085413 1 1
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000391 005-90032 261272277 34 6891
2026-07-21 8-K 8-K 5.07 0001193125-26-310315 001-38130 261190328 34 153324 1 1
2026-07-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002060757-26-000043 005-90032 261175537 34 14808
2026-06-08 ARS ARS 0001193125-26-260814 001-38130 261071199 34 1663599
2026-06-08 DEFA14A DEFA14A 0001193125-26-260812 001-38130 261071198 34 2044192
2026-06-08 DEF 14A DEF 14A 0001193125-26-260809 001-38130 261071197 34 5399079 1 1
2026-05-28 4 4 0001193125-26-245832 9860
2026-05-28 PRE 14A PRE 14A 0001193125-26-245389 001-38130 261037225 34 5397537 1 1
2026-05-15 10-Q 10-Q 0001193125-26-225352 001-38130 26982340 34 8026593 1 1
2026-05-13 4 4 0001193125-26-220718 7198
2026-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001697316-26-000012 005-90032 26956881 34 101695
2026-05-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-057607 005-90032 26956345 34 15605
2026-05-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002073679-26-000049 005-90032 26955286 34 103852
2026-05-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000227 005-90032 26947410 34 6769
2026-05-04 8-K 8-K 1.01,8.01,9.01 0001193125-26-204006 001-38130 26937720 34 580730 1 1
2026-05-04 424B5 424B5 0001193125-26-202429 333-295390 26934552 33 268227
2026-04-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001417 333-295390 26928606 33 1932
2026-04-28 CORRESP filename1.htm 0001193125-26-187839 8311
2026-04-28 CORRESP filename1.htm 0001193125-26-187838 10746
2026-04-28 S-1 S-1 0001193125-26-187803 333-295390 26909480 33 877386 1 1
2026-04-27 10-K/A 10-K/A 0001193125-26-178787 001-38130 26896446 34 1031741 1 1
2026-03-26 10-K 10-K 0001193125-26-126385 001-38130 26798814 34 13615903 1 1
2026-03-02 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-26-084012 001-38130 26703176 34 327750 1 1
2026-02-19 8-K 8-K 5.02 0001193125-26-059545 001-38130 26655066 34 139008 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000365 005-90032 26633025 34 15097
2026-01-16 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-26-015524 001-38130 26540472 34 342638 1 1
2025-12-31 UPLOAD filename1.pdf 0000000000-25-011914 377-08886 40616
2025-12-29 DRS filename1.htm 0001193125-25-335508 377-08886 251610089 33 349225
2025-12-11 8-K 8-K 1.02 0001193125-25-316225 001-38130 251565829 34 138945 1 1
2025-11-18 4 OWNERSHIP DOCUMENT 0000921895-25-003156 15581
2025-11-14 10-Q 10-Q 0001193125-25-281622 001-38130 251481318 34 9845034 1 1
2025-11-03 8-K 8-K 8.01,9.01 0001193125-25-261706 001-38130 251442140 34 157366 1 1
2025-10-28 4 OWNERSHIP DOCUMENT 0000921895-25-002819 20464
2025-10-24 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-25-250175 001-38130 251416893 34 148294 1 1
2025-10-09 8-K 8-K 8.01,9.01 0001193125-25-235152 001-38130 251383624 34 156243 1 1
2025-10-03 3 OWNERSHIP DOCUMENT 0000921895-25-002688 14119
2025-09-26 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-002628 005-90032 251351750 34 15238
2025-09-22 8-K 8-K 8.01 0001193125-25-210050 001-38130 251328452 34 148997 1 1
2025-09-09 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-25-198816 001-38130 251301696 34 148255 1 1
2025-09-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002855 333-290016 251298399 33 1933
2025-09-04 CORRESP filename1.htm 0001193125-25-196132 12702
2025-09-04 UPLOAD filename1.pdf 0000000000-25-009562 333-290016 40260
2025-09-03 S-1 S-1 0001193125-25-195041 333-290016 251290788 33 474396 1 1
2025-08-19 8-K 8-K 8.01,9.01 0001193125-25-183073 001-38130 251229692 34 152818 1 1
2025-08-14 10-Q 10-Q 0000950170-25-108836 001-38130 251218573 34 9621183 1 1
2025-07-30 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-25-168830 001-38130 251164274 34 690548 1 1
2025-07-30 424B5 424B5 0001193125-25-168827 333-287342 251164192 33 462024
2025-07-30 424B5 424B5 0001193125-25-168822 333-287342 251164138 33 89982
2025-07-23 4 4 0000950170-25-098046 5491
2025-07-23 4 4 0000950170-25-098044 5498
2025-07-23 4 4 0000950170-25-098043 5488
2025-07-23 4 4 0000950170-25-098041 5491
2025-07-23 4 4 0000950170-25-098039 5503
2025-07-23 8-K 8-K 5.07 0001193125-25-163400 001-38130 251143064 34 141559 1 1
2025-07-11 DEFA14A DEFA14A 0001193125-25-158200 001-38130 251119067 34 15786
2025-07-11 8-K 8-K 5.03,8.01,9.01 0001193125-25-158192 001-38130 251118976 34 161938 1 1
2025-06-24 DEFA14A DEFA14A 0001193125-25-145714 001-38130 251068929 34 16652
2025-06-24 8-K 8-K 8.01 0001193125-25-145711 001-38130 251068908 34 136677 1 1
2025-06-12 8-K 8-K 8.01 0001193125-25-139950 001-38130 251043064 34 142207 1 1
2025-05-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001721 333-287342 25979101 33 1932
2025-05-21 CORRESP filename1.htm 0001193125-25-123693 6642
2025-05-21 UPLOAD filename1.pdf 0000000000-25-005407 333-287342 40308
2025-05-16 S-3 S-3 0001193125-25-121358 333-287342 25957163 33 1551805
2025-05-15 8-K 8-K 2.02,9.01 0001193125-25-120824 001-38130 25953566 34 253926 1 1
2025-05-15 10-Q 10-Q 0000950170-25-072607 001-38130 25952843 34 7563813 1 1
2025-05-15 424B5 424B5 0001193125-25-120767 333-265470 25952391 33 8726
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-001483 005-90032 25948054 34 23448
2025-05-12 ARS ARS 0001193125-25-117833 001-38130 25935501 34 1011763
2025-05-12 DEFA14A DEFA14A 0001193125-25-117825 001-38130 25935398 34 511335
2025-05-12 DEF 14A DEF 14A 0001193125-25-117820 001-38130 25935306 34 2853084 1 1
2025-04-30 10-K/A 10-K/A 0001193125-25-107666 001-38130 25897668 34 755657 1 1
2025-04-22 8-K 8-K 1.01,3.02,9.01 0001193125-25-087955 001-38130 25855661 34 472855 1 1
2025-04-17 8-K 8-K 4.01,9.01 0001193125-25-084340 001-38130 25847477 34 161045 1 1
2025-04-07 10-K 10-K 0000950170-25-051566 001-38130 25818096 34 12949705 1 1
2025-03-31 NT 10-K NT 10-K 0001193125-25-068896 001-38130 25794814 34 25321
2025-01-10 8-K 8-K 5.03,8.01,9.01 0001193125-25-004443 001-38130 25522911 34 295593 1 1
2024-12-09 4 4 0000950170-24-134522 7749
2024-12-06 4 4 0000950170-24-134167 5289
2024-12-06 4 4 0000950170-24-134160 5304
2024-12-06 4 4 0000950170-24-134153 5289
2024-12-06 4 4 0000950170-24-134152 5296
2024-12-06 4 4 0000950170-24-134145 5286
2024-12-04 4 4 0000950170-24-133231 5384
2024-11-14 8-K 8-K 2.02,9.01 0001193125-24-258568 001-38130 241462082 34 197526 1 1
2024-11-14 10-Q 10-Q 0000950170-24-127019 001-38130 241461671 34 7009688 1 1
2024-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001019231-24-000036 005-90032 241428557 34 10394
2024-08-22 4 4 0000950170-24-099840 16526
2024-08-22 4 4 0000950170-24-099838 16558
2024-08-22 4 4 0000950170-24-099837 5375
2024-08-22 4 4 0000950170-24-099834 16146
2024-08-22 4 4 0000950170-24-099833 5372
2024-08-21 8-K 8-K 5.07,9.01 0001193125-24-204425 001-38130 241228926 34 158891 1 1
2024-08-14 8-K 8-K 2.02,9.01 0001193125-24-200739 001-38130 241209637 34 202534 1 1
2024-08-14 10-Q 10-Q 0000950170-24-097199 001-38130 241209485 34 6863426 1 1
2024-07-26 8-K 8-K 1.01,8.01,9.01 0001193125-24-186279 001-38130 241147573 34 440395 1 1
2024-07-26 424B5 424B5 0001193125-24-186271 333-265470 241147539 33 431759
2024-07-26 424B5 424B5 0001193125-24-186258 333-265470 241147331 33 809411
2024-07-09 ARS ARS 0001193125-24-176587 001-38130 241106409 34 1173206
2024-07-09 DEFA14A DEFA14A 0001193125-24-176586 001-38130 241106404 34 517952
2024-07-09 DEF 14A DEF 14A 0001193125-24-176585 001-38130 241106399 34 1259871
2024-06-17 4 PRIMARY DOCUMENT 0001019231-24-000026 7095
2024-06-12 4 PRIMARY DOCUMENT 0001019231-24-000025 11625
2024-06-07 4 PRIMARY DOCUMENT 0001019231-24-000024 11625
2024-06-05 8-K FORM 8-K 5.08,8.01 0001193125-24-154675 001-38130 241020685 34 151984 1 1
2024-05-16 3 3 0000950170-24-061212 14026
2024-05-16 8-K FORM 8-K 5.02 0001193125-24-140688 001-38130 24956535 34 150948 1 1
2024-05-15 8-K 8-K 2.02,9.01 0001193125-24-139510 001-38130 24952570 34 201969 1 1
2024-05-15 10-Q 10-Q 0000950170-24-060583 001-38130 24952453 34 6364362 1 1
2024-05-14 4/A PRIMARY DOCUMENT 0001019231-24-000023 28709
2024-05-01 4 PRIMARY DOCUMENT 0001019231-24-000022 40315
2024-05-01 8-K 8-K 1.01,8.01,9.01 0001193125-24-127657 001-38130 24904216 34 694613 1 1
2024-05-01 424B5 424B5 0001193125-24-127654 333-265470 24904207 33 687043
2024-05-01 S-8 S-8 0001193125-24-127637 333-279049 24904123 33 88662
2024-05-01 FWP FWP 0001193125-24-126495 333-265470 24900286 34 28892
2024-05-01 8-K 8-K 2.02,8.01 0001193125-24-126425 001-38130 24900228 34 162144 1 1
2024-04-30 3 PRIMARY DOCUMENT 0001019231-24-000021 5715
2024-04-29 144 xsl144X01/primary_doc.xml 0001972481-24-000106 001-38130 24892297 33 4834
2024-04-29 10-K/A 10-K/A 0001193125-24-120235 001-38130 24886755 34 704226 1 1
2024-04-16 SC 13D/A ff3271547_13da6-aileron.htm 0000895345-24-000124 005-90032 24848696 34 51665
2024-04-15 8-K 8-K 2.02,9.01 0001193125-24-096389 001-38130 24845509 34 211713 1 1
2024-04-15 10-K 10-K 0000950170-24-044508 001-38130 24845506 34 11351414 1 1
2024-04-10 4/A 4/A 0000950170-24-043362 5705
2024-04-10 4/A 4/A 0000950170-24-043361 5712
2024-04-02 3 3 0000950170-24-040478 6288
2024-04-01 NT 10-K NT 10-K 0001193125-24-083388 001-38130 24809473 34 27530
2024-03-29 8-K 8-K 5.02 0001193125-24-081562 001-38130 24802069 34 147179 1 1
2024-03-15 8-K 8-K 5.02,7.01,9.01 0001193125-24-068566 001-38130 24752437 34 173529 1 1
2024-03-06 4 4 0000950170-24-027304 7998
2024-03-05 SC 13G aileron13g3.txt 0001019231-24-000016 005-90032 24723524 34 10674
2024-03-05 SC 13D/A ff3106565_13da5-aileron.htm 0000895345-24-000084 005-90032 24721069 34 51117
2024-03-01 8-K 8-K 5.02,8.01 0001193125-24-055936 001-38130 24709658 34 141985 1 1
2024-03-01 4 4 0000950170-24-023840 20888
2024-03-01 4 4 0000950170-24-023839 20885
2024-02-29 8-K 8-K 5.02,5.03,5.07,8.01,9.01 0001193125-24-051759 001-38130 24698787 34 187112 1 1
2024-02-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-000463 005-90032 24633730 34 266198
2024-02-13 8-K 8-K 5.02 0001193125-24-032871 001-38130 24622555 34 141115 1 1
2024-02-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-05 16:30:00 9999999995-24-000319 333-276746 24597950 33 1752
2024-02-05 SC 13G/A ff2963798_13ga3-kapnick.htm 0000895345-24-000025 005-90032 24594978 34 56344
2024-02-01 CORRESP filename1.htm 0001193125-24-021895 5839
2024-02-01 UPLOAD filename1.pdf 0000000000-24-001266 333-276746 40285
2024-01-31 DEFA14A DEFA14A 0001193125-24-020912 001-38130 24582902 34 1166948
2024-01-29 S-8 S-8 0001193125-24-018119 333-276748 24573826 33 186364
2024-01-29 S-3 FORM S-3 0001193125-24-018105 333-276746 24573736 33 292176
2024-01-29 ARS ARS 0001193125-24-017535 001-38130 24570565 34 977767
2024-01-29 DEF 14A DEF 14A 0001193125-24-017532 001-38130 24570561 34 2654855
2024-01-29 8-K 8-K 5.08,8.01 0001193125-24-017476 001-38130 24570257 34 143159 1 1
2024-01-25 8-K FORM 8-K 8.01,9.01 0001193125-24-014835 001-38130 24558551 34 2037734 1 1
2024-01-19 PRE 14A PRE 14A 0001193125-24-011305 001-38130 24546168 34 2657858
2024-01-11 8-K/A FORM 8-K/A 9.01 0001193125-24-006614 001-38130 24529460 34 1229231 1 1
2024-01-10 8-K 8-K 3.01,4.01 0001193125-24-005933 001-38130 24526662 34 145958 1 1
2023-12-18 4 4 0000950170-23-071200 5400
2023-11-21 4 4 0000950170-23-065545 4764
2023-11-16 D xslFormDX01/primary_doc.xml 06b 0001420565-23-000002 021-497394 231412461 33 14122
2023-11-13 SC 13G SC 13G 0001104659-23-117321 005-90032 231399957 34 633873
2023-11-03 SC 13D/A ff2670875_13da4-aileron.htm 0000895345-23-000601 005-90032 231376817 34 61356
2023-11-02 4 FORM 4 SUBMISSION 0000899243-23-020117 5409
2023-11-02 4 FORM 4 SUBMISSION 0000899243-23-020116 5409
2023-11-02 3 FORM 3 SUBMISSION 0000899243-23-020115 9431
2023-11-02 3 FORM 3 SUBMISSION 0000899243-23-020113 9445
2023-11-02 3 FORM 3 SUBMISSION 0000899243-23-020110 20212
2023-10-31 8-K 8-K 1.01,2.01,3.02,4.01,5.02,5.03,7.01,8.01,9.01 0001193125-23-266990 001-38130 231363322 34 6770378 1 1
2023-10-13 10-Q 10-Q 0000950170-23-053302 001-38130 231325133 34 6195031 1 1
2023-08-11 10-Q 10-Q 0000950170-23-041839 001-38130 231164034 34 6720073 1 1
2023-05-08 10-Q 10-Q 0000950170-23-018476 001-38130 23895907 34 6365169 1 1
2023-04-28 10-K/A 10-K/A 0001193125-23-124375 001-38130 23860263 34 678055 1 1
2023-03-20 10-K 10-K 0000950170-23-008767 001-38130 23746532 34 11074800 1 1
2023-02-23 8-K 8-K 2.05,8.01 0001193125-23-046516 001-38130 23659600 34 152897 1 1
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000521 005-90032 23624939 34 276972
2023-02-14 SC 13G/A ff1759530_13ga2-kapnick.htm 0000895345-23-000118 005-90032 23622578 34 54977
2022-11-10 8-K 8-K 3.03,5.03,9.01 0001193125-22-282637 001-38130 221377510 34 170306 1 1
2022-11-01 10-Q 10-Q 0000950170-22-020709 001-38130 221348597 34 7118921 1 1
2022-08-15 10-Q 10-Q 0000950170-22-017372 001-38130 221165686 34 7045955 1 1
2022-07-08 8-K 8-K 5.02 0001193125-22-190531 001-38130 221074801 34 151490 1 1
2022-06-29 8-K 8-K 8.01 0001193125-22-184488 001-38130 221052118 34 170186 1 1
2022-06-21 424B5 424B5 0001193125-22-177771 333-265470 221029036 33 236630
2022-06-17 4 FORM 4 SUBMISSION 0000899243-22-023148 9942
2022-06-17 4 FORM 4 SUBMISSION 0000899243-22-023146 5257
2022-06-17 4 FORM 4 SUBMISSION 0000899243-22-023144 5403
2022-06-17 4 FORM 4 SUBMISSION 0000899243-22-023139 5365
2022-06-17 3 FORM 3 SUBMISSION 0000899243-22-023138 7599
2022-06-17 4 FORM 4 SUBMISSION 0000899243-22-023136 9929
2022-06-17 4 FORM 4 SUBMISSION 0000899243-22-023133 9954
2022-06-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-06-16 16:30:00 9999999995-22-001808 333-265470 221022321 33 1706
2022-06-16 8-K 8-K 5.02,5.07 0001193125-22-175284 001-38130 221019760 34 166482 1 1
2022-06-14 CORRESP filename1.htm 0001193125-22-173911 6264
2022-06-14 UPLOAD filename1.pdf 0000000000-22-006481 40210
2022-06-13 DEL AM DEL AM 0001193125-22-172884 333-265470 221011590 33 6703
2022-06-08 8-K 8-K 3.01 0001193125-22-170277 001-38130 221004101 34 150296 1 1
2022-06-08 S-3 S-3 0001193125-22-169400 333-265470 221002095 33 1483706
2022-06-07 8-K 8-K 5.02 0001193125-22-168878 001-38130 22999882 34 149356 1 1
2022-05-05 10-Q 10-Q 0000950170-22-007793 001-38130 22896017 34 6543625 1 1
2022-04-29 8-K 8-K 5.02 0001193125-22-134322 001-38130 22877620 34 147280 1 1
2022-04-29 DEFA14A DEFA14A 0001193125-22-133931 001-38130 22876007 34 1140044
2022-04-29 DEF 14A DEF 14A 0001193125-22-133908 001-38130 22875923 34 2429895
2022-04-15 PRE 14A PRE 14A 0001193125-22-106906 001-38130 22830583 34 2400232
2022-04-15 424B5 424B5 0001193125-22-106803 333-226650 22830170 33 10856
2022-03-30 4/A FORM 4/A SUBMISSION 0000899243-22-012858 5766
2022-03-30 4/A FORM 4/A SUBMISSION 0000899243-22-012857 5735
2022-03-30 4/A FORM 4/A SUBMISSION 0000899243-22-012856 5725
2022-03-30 4/A FORM 4/A SUBMISSION 0000899243-22-012855 5728
2022-03-28 10-K 10-K 0000950170-22-004774 001-38130 22775418 34 10525521 1 1
2022-03-24 4 FORM 4 SUBMISSION 0000899243-22-012150 5392
2022-03-24 4 FORM 4 SUBMISSION 0000899243-22-012149 5389
2022-03-24 4 FORM 4 SUBMISSION 0000899243-22-012148 5434
2022-03-24 4 FORM 4 SUBMISSION 0000899243-22-012144 5402
2022-02-14 SC 13G/A ff762158_13ga-kapnick.htm 0000895345-22-000175 005-90032 22625903 34 54348
2022-01-05 8-K 8-K 8.01 0001193125-22-002801 001-38130 22512417 34 158141 1 1
2021-12-07 8-K 8-K 3.01 0001193125-21-350289 001-38130 211476323 34 147036 1 1
2021-11-12 10-Q 10-Q 0001564590-21-056443 001-38130 211399482 34 7790604 1 1
2021-09-17 8-K 8-K 8.01 0001193125-21-275648 001-38130 211259275 34 172143 1 1
2021-09-13 8-K 8-K 7.01 0001193125-21-270831 001-38130 211248571 34 148578 1 1
2021-08-11 S-8 S-8 0001193125-21-243422 333-258717 211163824 33 89576
2021-08-11 10-Q 10-Q 0001564590-21-043417 001-38130 211163311 34 7644842 1 1
2021-07-01 8-K 8-K 8.01 0001193125-21-206326 001-38130 211066084 34 21579
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024533 5438
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024532 5489
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024531 5420
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024530 5412
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024528 5447
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024526 5260
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024525 5404
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024524 5458
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024522 5363
2021-06-17 4 FORM 4 SUBMISSION 0000899243-21-024521 5444
2021-06-17 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-21-193188 001-38130 211024844 34 118162
2021-05-11 10-Q 10-Q 0001564590-21-026527 001-38130 21911185 34 34387598 1
2021-04-28 DEFA14A DEFA14A 0001193125-21-137086 001-38130 21865200 34 749164
2021-04-28 DEF 14A DEF 14A 0001193125-21-137073 001-38130 21865126 34 1382127
2021-04-16 PRE 14A PRE 14A 0001193125-21-119482 001-38130 21832072 34 1382222
2021-03-31 8-K 8-K 1.01 0001193125-21-102330 001-38130 21793870 34 18864
2021-03-24 S-8 S-8 0001193125-21-092718 333-254659 21768735 33 56007
2021-03-24 10-K 10-K 0001564590-21-015115 001-38130 21768545 34 11350466 1
2021-03-02 8-K 8-K 8.01 0001193125-21-064672 001-38130 21701388 34 20617
2021-02-10 SC 13G/A 13G AMENDED ANNUAL FILING (ALRN) 0000053417-21-000005 005-90032 21609695 34 9112
2021-02-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-02-09 16:00:00 9999999995-21-000535 333-252587 21609080 33 1713
2021-02-09 SC 13G/A aile.htm 0001137774-21-000017 005-90032 21604959 34 9847
2021-02-05 CORRESP filename1.htm 0001193125-21-030640 8357
2021-02-04 UPLOAD filename1.pdf 0000000000-21-001462 40288
2021-01-29 S-3 S-3 0001193125-21-022819 333-252587 21572449 33 212793
2021-01-29 424B5 424B5 0001193125-21-022795 333-226650 21572147 33 370920
2021-01-29 8-K 8-K 1.01,9.01 0001193125-21-022774 001-38130 21572061 34 231349
2021-01-19 SC 13G THE SCHEDULE 13G 0000921895-21-000103 005-90032 21536386 34 289603
2021-01-08 4 FORM 4 SUBMISSION 0000899243-21-001163 6976
2021-01-08 SC 13D/A SC 13D/A 0001193125-21-005186 005-90032 21517506 34 36391
2021-01-07 424B5 424B5 0001193125-21-003786 333-226650 21513059 33 445965
2021-01-07 8-K 8-K 1.01,8.01,9.01 0001193125-21-003781 001-38130 21513058 34 198806
2021-01-06 8-K 8-K 8.01 0001193125-21-002690 001-38130 21509308 34 21363
2020-12-30 424B5 424B5 0001193125-20-329846 333-226650 201426087 33 295403
2020-12-21 8-K 8-K 7.01,8.01 0001193125-20-322457 001-38130 201402498 34 24255
2020-11-12 10-Q 10-Q 0001564590-20-053535 001-38130 201306477 34 7257446 1
2020-10-26 8-K 8-K 7.01,8.01,9.01 0001193125-20-276090 001-38130 201259098 34 555786
2020-10-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-10-15 16:00:00 9999999995-20-002868 333-249319 201242693 33 1662
2020-10-15 424B3 424B3 0001193125-20-270369 333-249319 201242208 33 223580
2020-10-13 CORRESP filename1.htm 0001193125-20-268405 6032
2020-10-08 UPLOAD filename1.pdf 0000000000-20-009507 40214
2020-10-05 S-1 S-1 0001193125-20-263968 333-249319 201224263 33 352147
2020-09-25 424B5 424B5 0001193125-20-254600 333-226650 201200351 33 303038
2020-09-22 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-20-250624 001-38130 201187857 34 285149
2020-09-14 8-K 8-K 7.01,8.01 0001193125-20-244673 001-38130 201172261 34 22706
2020-08-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-08-21 16:00:00 9999999995-20-002222 333-244367 201124500 33 1662
2020-08-19 CORRESP filename1.htm 0001193125-20-224217 6173
2020-08-18 UPLOAD filename1.pdf 0000000000-20-007567 40256
2020-08-11 S-3 S-3 0001193125-20-216321 333-244367 201092693 33 237046
2020-08-05 10-Q 10-Q 0001564590-20-036769 001-38130 201077120 34 6800593 1
2020-06-24 4 FORM 4 SUBMISSION 0000899243-20-017544 5346
2020-06-18 4 FORM 4 SUBMISSION 0000899243-20-017086 5312
2020-06-18 4 FORM 4 SUBMISSION 0000899243-20-017085 5349
2020-06-18 4 FORM 4 SUBMISSION 0000899243-20-017084 5205
2020-06-18 4 FORM 4 SUBMISSION 0000899243-20-017083 5365
2020-06-18 4 FORM 4 SUBMISSION 0000899243-20-017080 5356
2020-06-18 4 FORM 4 SUBMISSION 0000899243-20-017079 5356
2020-06-18 8-K 8-K 5.07 0001193125-20-171927 001-38130 20971306 34 25974
2020-06-17 4 FORM 4 SUBMISSION 0000899243-20-016859 4432
2020-06-12 CT ORDER filename1.pdf 20200612,20200612 9999999997-20-003617 333-218474 20959735 33 122582
2020-06-11 8-K 8-K 8.01 0001193125-20-166690 001-38130 20957535 34 18330
2020-06-09 4 FORM 4 SUBMISSION 0000899243-20-015869 4716
2020-06-09 4 FORM 4 SUBMISSION 0000899243-20-015868 6659
2020-06-09 SC 13D/A SC 13D/A 0001193125-20-164768 005-90032 20952710 34 33641
2020-06-08 SC 13G ja13g-aileron_kapnick.htm 0000895345-20-000689 005-90032 20950021 34 58568
2020-06-05 424B5 424B5 0001193125-20-162165 333-226650 20946111 33 533296
2020-06-05 8-K 8-K 1.01,8.01,9.01 0001193125-20-161540 001-38130 20944747 34 221954
2020-06-03 424B5 424B5 0001193125-20-159490 333-226650 20939967 33 536966
2020-06-03 424B5 424B5 0001193125-20-159482 333-226650 20939943 33 48745
2020-06-01 8-K 8-K 7.01,8.01,9.01 0001193125-20-156631 001-38130 20931147 34 1878228
2020-05-11 10-Q 10-Q 0001564590-20-023862 001-38130 20862676 34 5899926 1
2020-04-28 DEFA14A DEFA14A 0001193125-20-123300 001-38130 20826052 34 448277
2020-04-28 DEF 14A DEF 14A 0001193125-20-123293 001-38130 20826021 34 1637179
2020-04-22 8-K 8-K 7.01,8.01 0001193125-20-114425 001-38130 20806792 34 22249
2020-04-16 PRE 14A PRE 14A 0001193125-20-109322 001-38130 20796594 34 1642064
2020-04-16 SC 13D/A SC 13D/A 0001104659-20-047182 005-90032 20795190 34 96016
2020-04-13 SC 13D/A SC 13D/A 0001104659-20-045923 005-90032 20788812 34 98356
2020-03-30 S-8 S-8 0001193125-20-091054 333-237480 20758003 33 57731
2020-03-30 10-K 10-K 0001564590-20-014155 001-38130 20756927 34 10905635 1
2020-03-18 SC 13D/A SC 13D/A 0001104659-20-034979 005-90032 20723161 34 222229
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D 0001387131-20-001830 005-90032 20621035 34 55644
2020-02-14 SC 13G/A d8477759_13g-a.htm 0000919574-20-001429 005-90032 20615754 34 119118
2020-02-04 4 FORM 4 SUBMISSION 0000899243-20-002808 9847
2020-02-04 4 FORM 4 SUBMISSION 0000899243-20-002807 9877
2020-02-04 4 FORM 4 SUBMISSION 0000899243-20-002805 9839
2020-02-04 4 FORM 4 SUBMISSION 0000899243-20-002804 9878
2020-02-04 4 FORM 4 SUBMISSION 0000899243-20-002802 9813
2020-02-03 SC 13G/A 13G AMENDED ANNUAL FILING (ALRN) 0000053417-20-000009 005-90032 20568404 34 9059
2019-12-30 8-K 8-K 3.01 0001193125-19-325557 001-38130 191315098 34 20411
2019-11-18 4 FORM 4 SUBMISSION 0000899243-19-027510 5955
2019-11-14 4 FORM 4 SUBMISSION 0000899243-19-027279 4431
2019-11-12 SC 13G/A aile.htm 0001137774-19-000101 005-90032 191208501 34 9181
2019-11-08 SC 13G/A 13G - AMENDED MONTHLY FILING - ALRN 0000053417-19-000097 005-90032 191204559 34 9051
2019-11-07 10-Q ALRN-Q3-20190930 0001564590-19-041324 001-38130 191198014 34 7527344 1
2019-09-30 8-K 8-K 8.01 0001193125-19-258919 001-38130 191126685 34 22006
2019-09-16 4 FORM 4 SUBMISSION 0000899243-19-023645 7092
2019-09-09 8-K 8-K 5.02,9.01 0001193125-19-240551 001-38130 191081203 34 33125
2019-09-05 4 FORM 4 SUBMISSION 0000899243-19-022827 5020
2019-09-04 4 FORM 4 SUBMISSION 0000899243-19-022724 7092
2019-09-03 4 FORM 4 SUBMISSION 0000899243-19-022676 5017
2019-08-20 4 FORM 4 SUBMISSION 0000899243-19-022104 5044
2019-08-15 4 FORM 4 SUBMISSION 0000899243-19-021791 4494
2019-08-13 SC 13D/A SC 13D/A 0001144204-19-039589 005-90032 191021506 34 91649
2019-08-06 10-Q 10-Q 0001564590-19-029328 001-38130 191002092 34 7453933 1
2019-07-16 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-19-194006,2019-07-16 9999999995-19-001610 333-231143 19958160 33 1674
2019-07-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-07-15 16:00:00 9999999995-19-001591 333-226650 19956146 33 1661
2019-07-15 8-K FORM 8-K 3.01 0001193125-19-194040 001-38130 19955440 34 20107
2019-07-15 POS AM POS AM 0001193125-19-194006 333-231143 19955308 33 263733
2019-07-11 CORRESP filename1.htm 0001193125-19-192235 6401
2019-07-01 S-3/A S-3/A 0001193125-19-187446 333-226650 19933843 33 781104
2019-06-24 4 FORM 4 SUBMISSION 0000899243-19-017968 5262
2019-06-24 4 FORM 4 SUBMISSION 0000899243-19-017965 5117
2019-06-24 3 FORM 3 SUBMISSION 0000899243-19-017964 9418
2019-06-24 8-K 8-K 5.02,9.01 0001193125-19-180271 001-38130 19916190 34 37981
2019-06-24 3 FORM 3 SUBMISSION 0000899243-19-017961 7310
2019-06-21 4 FORM 4 SUBMISSION 0000899243-19-017794 5351
2019-06-21 4 FORM 4 SUBMISSION 0000899243-19-017793 5257
2019-06-21 4 FORM 4 SUBMISSION 0000899243-19-017792 5368
2019-06-21 4 FORM 4 SUBMISSION 0000899243-19-017791 5357
2019-06-21 4 FORM 4 SUBMISSION 0000899243-19-017788 5356
2019-06-20 8-K 8-K 5.07 0001193125-19-177496 001-38130 19908736 34 22677
2019-06-05 8-K FORM 8-K 8.01 0001193125-19-166179 001-38130 19880125 34 21955
2019-05-23 UPLOAD filename1.pdf 0000000000-19-008871 41974
2019-05-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-05-14 16:00:00 9999999995-19-001121 333-231143 19824845 33 1661
2019-05-13 S-1/A S-1/A 0001193125-19-145446 333-231143 19819074 33 319039
2019-05-10 CORRESP filename1.htm 0001193125-19-144108 6357
2019-05-08 10-Q FORM 10-Q 0001564590-19-017291 001-38130 19807419 34 6166035 1
2019-05-08 10-K/A 10-K/A 0001193125-19-141185 001-38130 19806149 34 34467
2019-05-07 UPLOAD filename1.pdf 0000000000-19-008164 45977
2019-05-01 S-1 S-1 0001193125-19-130164 333-231143 19784164 33 331840
2019-04-30 DEFA14A DEFA14A 0001193125-19-129788 001-38130 19783313 34 750741
2019-04-30 DEF 14A DEF 14A 0001193125-19-129758 001-38130 19783251 34 1216855
2019-04-26 SC 13G aile.htm 0001137774-19-000066 005-90032 19770319 34 9245
2019-04-17 4 FORM 4 SUBMISSION 0000899243-19-010819 5362
2019-04-17 4 FORM 4 SUBMISSION 0000899243-19-010818 5344
2019-04-17 4 FORM 4 SUBMISSION 0000899243-19-010815 5366
2019-04-17 4 FORM 4 SUBMISSION 0000899243-19-010813 5358
2019-04-17 4 FORM 4 SUBMISSION 0000899243-19-010812 5348
2019-04-17 4 FORM 4 SUBMISSION 0000899243-19-010811 5369
2019-04-11 SC 13D/A SC 13D/A 0001193125-19-103985 005-90032 19744432 34 54319
2019-04-10 SC 13D SC 13D 0001193125-19-102918 005-90032 19742195 34 53460
2019-04-09 SC 13G 13G INITIAL MONTHLY FILING - ALRN 0000053417-19-000081 005-90032 19739348 34 10295
2019-04-08 SC 13G d8216196_13-g.htm 0000919574-19-002794 005-90032 19738075 34 111936
2019-04-03 4 FORM 4 SUBMISSION 0000899243-19-009894 5225
2019-04-03 3 FORM 3 SUBMISSION 0000899243-19-009893 7432
2019-04-03 3 FORM 3 SUBMISSION 0000899243-19-009890 8768
2019-04-03 3 FORM 3 SUBMISSION 0000899243-19-009889 10696
2019-04-03 8-K 8-K 5.02,8.01,9.01 0001193125-19-096616 001-38130 19728937 34 35401
2019-04-03 SC 13D/A SC 13D/A 0001104659-19-019491 005-90032 19727423 34 101810
2019-04-02 4 PRIMARY DOCUMENT 0000925421-19-000143 9504
2019-04-01 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-19-093267 001-38130 19718583 34 553455
2019-03-29 S-8 S-8 0001193125-19-091512 333-230592 19713873 33 51750
2019-03-29 10-K 10-K 0001564590-19-010007 001-38130 19713820 34 10480271 1
2019-03-18 SC 13D/A SC 13D/A 0001104659-19-015611 005-90032 19688654 34 226664
2019-03-15 4 PRIMARY DOCUMENT 0000925421-19-000114 11462
2019-03-01 8-K 8-K 5.02 0001193125-19-061077 001-38130 19649880 34 15187
2019-02-25 4 FORM 4 SUBMISSION 0000899243-19-004732 5387
2019-02-25 3 FORM 3 SUBMISSION 0000899243-19-004731 7514
2018-11-16 8-K 8-K 7.01 0001193125-18-328314 001-38130 181188562 34 13417
2018-11-07 10-Q 10-Q 0001564590-18-027987 001-38130 181166187 34 5865249 1
2018-11-06 4 FORM 4 SUBMISSION 0000899243-18-028339 5419
2018-11-06 3 FORM 3 SUBMISSION 0000899243-18-028338 13955
2018-11-06 3 FORM 3 SUBMISSION 0000899243-18-028336 7633
2018-10-01 8-K 8-K 5.02 0001193125-18-289677 001-38130 181098212 34 16641
2018-09-07 4 FORM 4 SUBMISSION 0000899243-18-024025 5369
2018-09-06 8-K 8-K 5.02,9.01 0001193125-18-267768 001-38130 181056745 34 36276
2018-08-22 SC 13D/A SC 13D/A 0001104659-18-053210 005-90032 181032853 34 223567
2018-08-22 4 PRIMARY DOCUMENT 0000925421-18-000300 7454
2018-08-20 4 PRIMARY DOCUMENT 0000925421-18-000294 9463
2018-08-17 8-K 8-K 5.07 0001193125-18-251712 001-38130 181025987 34 22051
2018-08-16 4 PRIMARY DOCUMENT 0000925421-18-000292 9463
2018-08-15 UPLOAD filename1.pdf 0000000000-18-025320 45938
2018-08-14 4 FORM 4 SUBMISSION 0000899243-18-022378 5059
2018-08-14 4 PRIMARY DOCUMENT 0000925421-18-000290 9463
2018-08-14 4/A FORM 4/A SUBMISSION 0000899243-18-022295 5517
2018-08-10 4 PRIMARY DOCUMENT 0000925421-18-000284 9452
2018-08-08 4 PRIMARY DOCUMENT 0000925421-18-000282 9453
2018-08-07 S-3 S-3 0001193125-18-241115 333-226650 18998650 33 1139358
2018-08-07 10-Q Q2 2018 10-Q 0001564590-18-019901 001-38130 18997888 34 6536775 1

Latest XBRL company facts

One latest value per concept from companyfacts (292 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 86.27M 2026-11-12 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
dei EntityPublicFloat Entity Public Float USD 32.26M 2025-06-30 2025 FY 10-K/A 2026-04-27 0001193125-26-178787
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 0 2025-01-01 2025-12-31 DEF 14A 2026-06-08 0001193125-26-260809
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 0 2025-01-01 2025-12-31 DEF 14A 2026-06-08 0001193125-26-260809
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 0 2023-01-01 2023-12-31 DEF 14A 2026-06-08 0001193125-26-260809
ecd PeoTotalCompAmt PeoTotalCompAmt USD 0 2023-01-01 2023-12-31 DEF 14A 2026-06-08 0001193125-26-260809
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD -54.85 2025-01-01 2025-12-31 DEF 14A 2026-06-08 0001193125-26-260809
ffd NetFeeAmt NetFeeAmt USD 8,298.08 2026-04-28 S-1 2026-04-28 0001193125-26-187803
ffd TtlFeeAmt TtlFeeAmt USD 8,298.08 2026-04-28 S-1 2026-04-28 0001193125-26-187803
ffd TtlOfferingAmt TtlOfferingAmt USD 60.09M 2026-04-28 S-1 2026-04-28 0001193125-26-187803
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-28 S-1 2026-04-28 0001193125-26-187803
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-28 S-1 2026-04-28 0001193125-26-187803
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.20M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 2.40M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 350,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 358,000 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -115,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 426.73M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 41,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010007
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 534,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 404,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 741,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 854,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 24.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap Assets Assets USD 59.43M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AssetsCurrent Assets, Current USD 36.78M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 10.37M 2017-06-30 2017 Q2 10-Q 2017-08-10 0001193125-17-254426
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 60,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 35.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 35.54M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -28.23M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 153,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets USD 79.20M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281622
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 2.87M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 943,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -8.85M 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 36.49M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 7.44M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012373
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 943,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -2.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 1.6 2025-04-21 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 612,269 2022-12-31 2022 FY 10-K 2023-03-20 0000950170-23-008767
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 86.27M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 86.27M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 22,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108836
us-gaap CommonStockValue Common Stock, Value, Issued USD 172,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -17.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ConstructionInProgressExpendituresIncurredButNotYetPaid Construction in Progress Expenditures Incurred but Not yet Paid USD 6.62M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-027987
us-gaap ConstructionLoanNoncurrent Long-term Construction Loan, Noncurrent USD 5.34M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 10.46M 2016-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 190,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-05 0001564590-20-036769
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-350270
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2017-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -1.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -712,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.29M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.22M 2017-06-30 2017 Q2 10-Q 2017-08-10 0001193125-17-254426
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 11,000 2016-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 624,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 44.36M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.23M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 28.68M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 5.72M 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004774
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 508,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 271,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 42.13M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.06M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010007
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 99,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap Depreciation Depreciation USD 49,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.09 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007793
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.173 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.027 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004774
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 746,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007793
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007793
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -16,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-13 0000950170-23-053302
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap Goodwill Goodwill USD 6.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 28.70M 2025-10-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -712,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 8.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -10.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 737,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -76,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 619,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -869,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 195,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -712,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -852,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041324
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 1.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 181,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 25,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 13.50M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 13.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 19.83M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap InterestAndOtherIncome Interest and Other Income USD 228,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023244
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 322,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-13 0000950170-23-053302
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 494,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap LeaseCost Lease, Cost USD 184,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 48,000 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.13M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041324
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 48,000 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.12M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041324
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.12M 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.09M 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.06M 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 254,000 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041324
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 0 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap Liabilities Liabilities USD 6.66M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 59.43M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap LiabilitiesCurrent Liabilities, Current USD 5.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap LongTermInvestments Long-term Investments USD 994,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 52.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 16,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012373
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -35.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 2.40M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012373
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -19.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -6.93M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012373
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -17.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -29.37M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap NotesPayableCurrent Notes Payable, Current USD 4.92M 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-225352
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OperatingExpenses Operating Expenses USD 18.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -18.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OperatingLeaseCost Operating Lease, Cost USD 184,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 48,000 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 48,000 2023-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 69,000 2021-12-31 2022 FY 10-K 2023-03-20 0000950170-23-008767
us-gaap OperatingLeasePayments Operating Lease, Payments USD 743,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041324
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 40,000 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 8.42M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 997,000 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.12M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.09M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.06M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.03M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.07 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -53,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -57,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 555,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap PaymentsForRestructuring Payments for Restructuring USD 928,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-10-13 0000950170-23-053302
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 893,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281622
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 21.85M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 994,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 157,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-20 0000950170-23-008767
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 35.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2022-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ProceedsFromCollaborators Proceeds from Collaborators USD 34.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap ProceedsFromConstructionLoansPayable Proceeds from Construction Loans Payable USD 2.47M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 53.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 626,000 2017-02-01 2017-02-28 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 552,000 2017-07-04 2021 Q1 10-Q 2021-05-11 0001564590-21-026527
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 4.42M 2019-04-01 2019-04-30 2021 Q1 10-Q 2021-05-11 0001564590-21-026527
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 999,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -17.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 640,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001564590-21-015115
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 377,000 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap PurchaseObligation Purchase Obligation USD 2.34M 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060583
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 5.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 11.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap RestrictedCash Restricted Cash USD 0 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281622
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 25,000 2023-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 568,000 2019-12-31 2020 FY 10-K 2021-03-24 0001564590-21-015115
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-20 0000950170-23-008767
us-gaap RestructuringCharges Restructuring Charges USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 12,000 2023-09-30 2023 Q3 10-Q 2023-10-13 0000950170-23-053302
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -419.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap Revenues Revenues USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012373
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 2.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 255,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 854,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.053 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.91 2023-10-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.75 2023-10-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.056 2023-10-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.048 2023-10-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 31,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.36M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.28 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 18,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 280,366 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 52,377 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 472,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 36,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.28M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.89 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 36,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 3.25M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 2.91 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 462,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 26.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1.36 2017-02-28 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap ShortTermInvestments Short-term Investments USD 34.55M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 52.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.05 2022-11-10 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares -1 2024-04-01 2024-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108836
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 403,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD -1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 49.83M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap StraightLineRent Straight Line Rent USD 11,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014155
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 41,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010007
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 41,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010007
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 45.01M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 0 2017-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010007
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 130.05M 2016-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 24,610 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 12,232 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 16.80M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-15 0000950170-24-044508
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 0 2024-12-31 2024 FY 10-K 2025-04-07 0000950170-25-051566
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 11.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126385
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 62.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 90.67M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007793
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 62.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-461944
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 1.50M 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007403

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →